CA2873570C - Amides of 2-amino-4-arylthiazole compounds and their salts as trpa1 modulators - Google Patents
Amides of 2-amino-4-arylthiazole compounds and their salts as trpa1 modulators Download PDFInfo
- Publication number
- CA2873570C CA2873570C CA2873570A CA2873570A CA2873570C CA 2873570 C CA2873570 C CA 2873570C CA 2873570 A CA2873570 A CA 2873570A CA 2873570 A CA2873570 A CA 2873570A CA 2873570 C CA2873570 C CA 2873570C
- Authority
- CA
- Canada
- Prior art keywords
- formula
- compound
- another embodiment
- potassium salt
- trifluoromethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1687/MUM/2012 | 2012-06-08 | ||
| IN1687MU2012 | 2012-06-08 | ||
| US201261665282P | 2012-06-27 | 2012-06-27 | |
| US61/665,282 | 2012-06-27 | ||
| IN3519MU2012 | 2012-12-13 | ||
| IN3519/MUM/2012 | 2012-12-13 | ||
| US201261748016P | 2012-12-31 | 2012-12-31 | |
| US61/748,016 | 2012-12-31 | ||
| PCT/IB2013/054703 WO2013183035A2 (en) | 2012-06-08 | 2013-06-08 | Amides of 2-amino-4-arylthiazole compounds and their salts |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2873570A1 CA2873570A1 (en) | 2013-12-12 |
| CA2873570C true CA2873570C (en) | 2016-11-01 |
Family
ID=54193746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2873570A Active CA2873570C (en) | 2012-06-08 | 2013-06-08 | Amides of 2-amino-4-arylthiazole compounds and their salts as trpa1 modulators |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US9458173B2 (enExample) |
| EP (1) | EP2858999B1 (enExample) |
| JP (1) | JP5989900B2 (enExample) |
| KR (1) | KR20150015488A (enExample) |
| CN (1) | CN104350058A (enExample) |
| AP (1) | AP3546A (enExample) |
| AU (1) | AU2013273118B2 (enExample) |
| BR (1) | BR112014029155A2 (enExample) |
| CA (1) | CA2873570C (enExample) |
| CL (1) | CL2014003317A1 (enExample) |
| EA (1) | EA031334B1 (enExample) |
| HK (1) | HK1207643A1 (enExample) |
| IL (1) | IL236084A0 (enExample) |
| IN (1) | IN2014MN02467A (enExample) |
| MX (1) | MX354014B (enExample) |
| MY (1) | MY165622A (enExample) |
| NZ (1) | NZ701721A (enExample) |
| PE (1) | PE20142306A1 (enExample) |
| PH (1) | PH12014502685B1 (enExample) |
| SG (1) | SG11201408093PA (enExample) |
| WO (1) | WO2013183035A2 (enExample) |
| ZA (1) | ZA201500082B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ724503A (en) | 2012-06-08 | 2017-12-22 | Gilead Sciences Inc | Macrocyclic inhibitors of flaviviridae viruses |
| AR091279A1 (es) | 2012-06-08 | 2015-01-21 | Gilead Sciences Inc | Inhibidores macrociclicos de virus flaviviridae |
| CA2912578A1 (en) * | 2013-06-20 | 2014-12-24 | Glenmark Pharmaceuticals S.A. | Nanoparticulate formulation comprising a trpa1 antagonist |
| EP3180345B1 (en) * | 2014-08-11 | 2018-10-10 | Hydra Biosciences, Inc. | Thieno- and furo[2,3-d]pyrimidine-2,4[1h,3h]-dione derivatives as trpc5 modulators for the treatment of neuropsychiatric disorders |
| WO2016042501A1 (en) * | 2014-09-16 | 2016-03-24 | Glenmark Pharmaceuticals S.A. | Trpa1 antagonist for the treatment of pain associated to diabetic neuropathic pain |
| TW202321229A (zh) | 2021-08-18 | 2023-06-01 | 美商富曼西公司 | 殺真菌的取代的雜環化合物 |
| CN114671875A (zh) * | 2022-04-27 | 2022-06-28 | 成都施贝康生物医药科技有限公司 | 新型二氢嘧啶类化合物、异构体或盐及其制备方法和用途 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2248231A1 (de) | 1972-10-02 | 1974-04-11 | Basf Ag | 3-aminoisothiazolo eckige klammer auf 3,4-d eckige klammer zu pyrimidine |
| SE9701398D0 (sv) | 1997-04-15 | 1997-04-15 | Astra Pharma Prod | Novel compounds |
| ES2193839B1 (es) * | 2001-06-22 | 2005-02-16 | Almirall Prodesfarma, S.A. | Nuevos derivados de 6-fenildihidropirrolpirimidindiona. |
| AU2003253165A1 (en) * | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Pyrimidine fused bicyclic metalloproteinase inhibitors |
| US6890923B2 (en) | 2002-12-16 | 2005-05-10 | Astrazeneca Ab | Compounds |
| US7465581B2 (en) | 2002-12-18 | 2008-12-16 | The Scripps Research Institute | ANKTM1, a cold-activated TRP-like channel expressed in nociceptive neurons |
| EP1657238A4 (en) | 2003-08-22 | 2008-12-03 | Takeda Pharmaceutical | CONDENSATE PYRIMIDINE DERIVATIVE AND ITS USE |
| EP1713815A4 (en) | 2004-02-11 | 2009-03-11 | Smithkline Beecham Corp | PTH AGONISTS |
| US20070196866A1 (en) | 2004-03-13 | 2007-08-23 | Irm Llc | Modulators of ion channel trpa1 |
| EP1847541A4 (en) | 2005-02-03 | 2009-12-30 | Takeda Pharmaceutical | CONDENSED PYRIMIDINE DERIVATIVE AND USE THEREOF |
| AU2006278592A1 (en) | 2005-08-04 | 2007-02-15 | Apogee Biotechnology Corporation | Sphingosine kinase inhibitors and methods of their use |
| US20070105920A1 (en) | 2005-11-08 | 2007-05-10 | Akzo Nobel N.V. | 2-(Benzimidazol-1-Yl)-N-(4-phenylthiazol-2-yl) acetamide derivatives |
| TW201900217A (zh) | 2005-12-22 | 2019-01-01 | 美商海卓勒生物科學公司 | 用於調節ｔｒｐａ１功能之化合物 |
| TW200800997A (en) | 2006-03-22 | 2008-01-01 | Astrazeneca Ab | Chemical compounds |
| CN101454318A (zh) * | 2006-03-22 | 2009-06-10 | 阿斯利康(瑞典)有限公司 | 吡啶并嘧啶衍生物及其作为pde4抑制剂的用途 |
| JP2011201776A (ja) | 2008-07-23 | 2011-10-13 | Mochida Pharmaceut Co Ltd | ヘテロシクリデン−ｎ−（３，４−ジヒドロ−２（１ｈ）−キナゾリノン−５−イル）アセトアミド誘導体 |
| CL2008000252A1 (es) | 2007-01-29 | 2008-03-14 | Xenon Pharmaceuticals Inc | Compuestos derivados de quinazolinona o pirimidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar enfermedades mediadas por los canales de calcio, tales como dolor, depresion, enfermedades cardiovasculares, respir |
| SI3184527T1 (sl) | 2007-06-22 | 2020-03-31 | Eli Lilly And Company | Spojine 2,6-diokso,-2,3-dihidro-1H-purina uporabne za zdravljenje stanj povezanih z aktivnostjo TRPA1 kanala |
| WO2010004390A1 (en) * | 2008-06-17 | 2010-01-14 | Glenmark Pharmaceuticals, S.A. | Quinazoline dione derivatives as trpa1 modulators |
| WO2009158719A2 (en) | 2008-06-27 | 2009-12-30 | Hydra Biosciences, Inc. | Methods and compositions for treating disorders |
| EP2411395B1 (en) * | 2009-03-23 | 2013-05-29 | Glenmark Pharmaceuticals S.A. | Furopyrimidinedione derivatives as trpa1 modulators |
| DK2411397T3 (da) | 2009-03-23 | 2013-08-05 | Glenmark Pharmaceuticals Sa | Isothiazol-pyrimidindionderivater som modulatorer af TRPA1 |
| US8623880B2 (en) | 2009-03-23 | 2014-01-07 | Glenmark Pharmaceuticals S.A. | Fused pyrimidine-dione derivatives as TRPA1 modulators |
| BRPI1013559A2 (pt) | 2009-03-23 | 2016-04-12 | Glenmark Pharmaceuticals Sa | compostos, composição farmacêutica, método de tratamento de doença ou condição associada à função trpa1 e respectivos usos |
| AR084294A1 (es) | 2010-12-20 | 2013-05-08 | Glenmark Pharmaceuticals Sa | Compuestos de 2-amino-4-ariltiazol, metodos para su sintesis y uso como antagonista de trpa1 |
-
2013
- 2013-06-08 IN IN2467MUN2014 patent/IN2014MN02467A/en unknown
- 2013-06-08 WO PCT/IB2013/054703 patent/WO2013183035A2/en not_active Ceased
- 2013-06-08 EA EA201492054A patent/EA031334B1/ru unknown
- 2013-06-08 PE PE2014002226A patent/PE20142306A1/es not_active Application Discontinuation
- 2013-06-08 BR BR112014029155A patent/BR112014029155A2/pt not_active Application Discontinuation
- 2013-06-08 US US14/402,608 patent/US9458173B2/en not_active Expired - Fee Related
- 2013-06-08 NZ NZ701721A patent/NZ701721A/en not_active IP Right Cessation
- 2013-06-08 SG SG11201408093PA patent/SG11201408093PA/en unknown
- 2013-06-08 EP EP13742279.6A patent/EP2858999B1/en active Active
- 2013-06-08 CN CN201380030184.XA patent/CN104350058A/zh active Pending
- 2013-06-08 AP AP2014008076A patent/AP3546A/xx active
- 2013-06-08 JP JP2015515642A patent/JP5989900B2/ja not_active Expired - Fee Related
- 2013-06-08 HK HK15108333.2A patent/HK1207643A1/xx unknown
- 2013-06-08 KR KR1020147033855A patent/KR20150015488A/ko not_active Abandoned
- 2013-06-08 AU AU2013273118A patent/AU2013273118B2/en not_active Ceased
- 2013-06-08 MY MYPI2014003389A patent/MY165622A/en unknown
- 2013-06-08 MX MX2014014482A patent/MX354014B/es active IP Right Grant
- 2013-06-08 CA CA2873570A patent/CA2873570C/en active Active
-
2014
- 2014-12-02 PH PH12014502685A patent/PH12014502685B1/en unknown
- 2014-12-04 IL IL236084A patent/IL236084A0/en unknown
- 2014-12-04 CL CL2014003317A patent/CL2014003317A1/es unknown
-
2015
- 2015-01-07 ZA ZA2015/00082A patent/ZA201500082B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150015488A (ko) | 2015-02-10 |
| MY165622A (en) | 2018-04-18 |
| PE20142306A1 (es) | 2015-01-16 |
| SG11201408093PA (en) | 2015-01-29 |
| HK1207643A1 (en) | 2016-02-05 |
| IN2014MN02467A (enExample) | 2015-07-10 |
| AP3546A (en) | 2016-01-14 |
| BR112014029155A2 (pt) | 2017-06-27 |
| JP5989900B2 (ja) | 2016-09-07 |
| MX354014B (es) | 2018-02-08 |
| AU2013273118B2 (en) | 2015-11-05 |
| WO2013183035A2 (en) | 2013-12-12 |
| IL236084A0 (en) | 2015-02-01 |
| CN104350058A (zh) | 2015-02-11 |
| MX2014014482A (es) | 2015-06-05 |
| US20150111038A1 (en) | 2015-04-23 |
| CA2873570A1 (en) | 2013-12-12 |
| WO2013183035A3 (en) | 2014-02-27 |
| EA201492054A1 (ru) | 2016-08-31 |
| AU2013273118A1 (en) | 2014-11-27 |
| PH12014502685A1 (en) | 2015-01-26 |
| ZA201500082B (en) | 2015-12-23 |
| PH12014502685B1 (en) | 2015-01-26 |
| NZ701721A (en) | 2016-03-31 |
| JP2015520183A (ja) | 2015-07-16 |
| CL2014003317A1 (es) | 2015-02-13 |
| EP2858999A2 (en) | 2015-04-15 |
| EP2858999B1 (en) | 2017-05-10 |
| AP2014008076A0 (en) | 2014-11-30 |
| US9458173B2 (en) | 2016-10-04 |
| EA031334B1 (ru) | 2018-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2873570C (en) | Amides of 2-amino-4-arylthiazole compounds and their salts as trpa1 modulators | |
| US5338756A (en) | Benzimidazole compounds | |
| DE69304243T2 (de) | Chinolin-Verbindungen als Angiotensin-II-Antagoniste | |
| US20100261908A1 (en) | Processes for the preparation of prasugrel , and its salts and polymorphs | |
| DE69711430T2 (de) | PYRROLO[3,4-d]PYRIMIDINON-DERIVATE UND IHRE VERWENDUNG ALS IMMUNOSUPPRESSOREN | |
| KR20020015394A (ko) | 티로신 단백질 키나아제 Ｓｙｋ의 푸린 유도체 억제제 | |
| US20100041699A1 (en) | Microcrystalline (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl) acetic acid | |
| KR20130102099A (ko) | Trpa1 길항제로서의 2-아미노-4-아릴티아졸 화합물 | |
| JP3014001B2 (ja) | 興奮性アミノ酸拮抗剤 | |
| JP2023553291A (ja) | Ｔｒｐｍ３媒介性障害を治療するためのアリール誘導体 | |
| CN113278012B (zh) | 用作激酶抑制剂的化合物及其应用 | |
| DE2323149C3 (de) | Thienopyrimidine, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneipräparate | |
| Song et al. | Facile synthesis and antitumor activity of novel 2-trifluoromethylthieno [2, 3-d] pyrimidine derivatives | |
| JPH0336835B2 (enExample) | ||
| SE466656B (sv) | Nya mellanprodukter anvaendbara foer framstaellning av 4-hydroxi-3-kinolinkarboxylsyraderivat | |
| US5281708A (en) | 9-Substituted-8-halo or -8-hydroxy-9-deazaguanines as inhibitors of PNP | |
| JPH07252260A (ja) | 新規チエノチアジン誘導体、その製造方法及びその使用方法 | |
| CN113336703B (zh) | 1,3,4,5-四取代1h-吡唑衍生物的合成 | |
| DE602005002847T2 (de) | Thienopyridoncarbonsäureamide und deren medizinische verwendung | |
| KR920001673B1 (ko) | 피리미도이소퀴놀린 유도체의 제조방법 | |
| JP2023539526A (ja) | インターフェロン遺伝子刺激因子ｓｔｉｎｇのアゴニスト | |
| Bahshwan et al. | Synthesis and Pharmacological activities of some Thieno pyridazine derivatives using 5-Amino-4-Ethoxycarbonyl Phenanthro [9, 10-e] Theino [2, 3-c] Pyridazine as a starting material | |
| DD220307A5 (de) | Verfahren zur herstellung von polycyclische carbonsaeureverbindungen | |
| JP3145364B2 (ja) | 新規化合物及び該化合物を含有する医薬組成物 | |
| WO2021110138A1 (zh) | 噻吩并[2,3-c]哒嗪-4(1H)-酮类化合物的晶型及其制备方法和应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20141113 |